Table:
begin	end	state
1	20	cytoplasmic
21	42	transmembrane
43	50	non-cytoplasmic
51	74	transmembrane
75	94	cytoplasmic
95	119	transmembrane
120	130	non-cytoplasmic
131	153	transmembrane
154	162	cytoplasmic
163	185	transmembrane
186	204	non-cytoplasmic
205	227	transmembrane
228	247	cytoplasmic
248	266	transmembrane
267	292	non-cytoplasmic
293	313	transmembrane
314	338	cytoplasmic
339	359	transmembrane
360	364	non-cytoplasmic
365	390	transmembrane
391	410	cytoplasmic
411	431	transmembrane
432	436	non-cytoplasmic
437	455	transmembrane
456	476	cytoplasmic

Input:
>Pf6N2E2_4959 FitnessBrowser__pseudo6_N2E2:Pf6N2E2_4959
MSIKEQQLNTRAGFKQEMQTRHIVMLALGGVIGTGLFLTSGYTVNQAGPMGAVIAYIIGA
LMVYMVMMCLGELAVQMPETGSFSTYATRFLGPGTGYTVAWLYWLTWTVAIGSEFTAAGI
LMSRWFPDTPVWIWSALFAGVVFLSNVISVRLFAETEFWLSLIKVLTVVVFLLIGGGAIL
GLLNIDQAHSIGLSNFTREGLFPTGFMPIAMTLLAVSFAFSGTELIGIAAGETKDPQRNV
PRAIRTTVLRLAVFFVGTIFVLATLLPREQAGLVESPFVTVFTYIGIPYSADIMNFVIIS
ALLSAANSGLYAASRMLWTLSDQGHLPKQFSALTRMGTPLNAIIVSMAGGAASLLSSVFA
ADTIYLALVSISGLAVVVVWMSIAASQIAFRRHYVANGGDIRKLKFRVRGYPWVPLGALV
CCSLACIGIAFDPEQRVALYFGLPFIAWCYFVYYITRKSRERRLSVAFVAQPSDAF

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server